Skip to main content
Veterinary Medicines

Flunazine 50 mg/ml Solution for Injection for cattle, horses and pigs

Authorised
  • Flunixin meglumine

Product identification

Medicine name:
Flunazine 50 mg/ml Solution for Injection for cattle, horses and pigs
Cronyxin 50 mg/ml oplossing voor injectie voor rundvee, paarden en varkens
Active substance:
  • Flunixin meglumine
Target species:
  • Pig
  • Cattle
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Flunixin meglumine
    83.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        24
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        10
        day
      • Milk
        48
        hour
    • Horse
      • Meat and offal
        28
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AG90
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • 50 ml clear Type I glass Multidose vial, with Bromobutyl rubber bung.
  • 100 ml clear Type I glass Multidose vial, with Bromobutyl rubber bung.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 9975
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0125/001
Concerned member states:
  • Belgium
  • Germany
  • Italy
  • Luxembourg
  • Netherlands
  • Spain

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 31/01/2024

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."